ArticleTherapeutic advances in medical oncology2025

A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer.

Yvonne L E Ang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.